AI-Driven Biological Discovery

What would you like to discover today?

Your AI research agent. Analyze molecular data, predict protein interactions, design novel therapeutics, and mine 35M+ biomedical publications — all from a single prompt.

auto_awesome

Built for serious research

Everything you need to accelerate your next breakthrough — from data mining to structure generation.

database

PubMed & NCBI Integration

Access over 35 million biomedical articles, genomic datasets, and protein structures in real-time. Our agent mines PubMed, GenBank, UniProt, and PDB to enrich every analysis with the latest evidence.

clinical_notes

Automated wet-lab validation

State-of-the-art models like Boltzgen and Drugclip are amazing but of course need to be validated in the lab— all orchestrated by a single intelligent agent.

groups

Custom synthesis

If you want to continue your research custom synthesis can be arranged with delivery to your research facility.

Agent Toolbox

Powered by state-of-the-art models

Our research agent autonomously selects and orchestrates the right tools for your query — from generative protein design to small molecule binding prediction. No manual setup, no scripting required.

check_circle
Boltzgen — Generative protein structure prediction & optimization
check_circle
Drugclip — AI-driven accurate virtual screening in molecule library
check_circle
PubMed & NCBI — Real-time literature & genomic data retrieval
check_circle
CellType Agent — Biological reasoning & agentic research

agent_pipeline.log

Query: "Design a binder for PD-L1 ectodomain"

library_books

PubMed: Retrieved 12 relevant structures…

PMIDs: 34526721, 33245890, 35124567…

science

Drugclip: Screening 500 million compounds…

bolt

Boltzgen: Optimizing top 3 candidates…

check_circle

Done — 3 high-affinity binders generated

Best ΔG: -12.4 kcal/mol | RMSD: 0.8 Å

Agent Active

4 tools orchestrated

12.3s total execution

Explore

Trending biological targets

Curated from the latest PubMed and NCBI publications — start your research from the cutting edge.

Oncology arrow_outward

KRAS G12C

Oncogenic driver mutation — major target for lung and colorectal cancers

article 2,847 papers (2024–25)

Immunology arrow_outward

PD-L1 / PD-1

Immune checkpoint axis — backbone of cancer immunotherapy

article 5,120 papers (2024–25)

Kinase arrow_outward

EGFR

Receptor tyrosine kinase — key target in non-small cell lung cancer

article 3,215 papers (2024–25)

Metabolic arrow_outward

GLP-1R

Glucagon-like peptide-1 receptor — revolutionary target for diabetes & obesity

article 4,692 papers (2024–25)

Cardiovascular arrow_outward

PCSK9

Proprotein convertase — validated target for cardiovascular disease prevention

article 1,890 papers (2024–25)

Neurology arrow_outward

TDP-43

RNA-binding protein — emerging target in ALS & frontotemporal dementia

article 1,456 papers (2024–25)

Gene Editing arrow_outward

BRCA1

Tumor suppressor gene — CRISPR-guided therapeutic target for hereditary breast cancer

article 2,103 papers (2024–25)

Immuno-oncology arrow_outward

CD47 / SIRPα

"Don't eat me" signal — innate immune checkpoint for hematological cancers

article 1,780 papers (2024–25)